2016 American Transplant Congress
Evolution of Donor Nephrectomy: Long-Term Outcomes with Four Different Techniques Between 1963 and 2014 at a Single Institution.
PURPOSE: The development of minimally-invasive approaches to donor nephrectomy (DN) has been primarily driven by the potential advantages it presents the donor. Questions remain over…2016 American Transplant Congress
Outcomes of Ductoplasty in Right Lobe Living Donor Grafts with More Than One Bile Duct.
Background:Biliary complications remain the Achilles's heel of LDLT, especially in the setting of multiple ducts in the right lobe graft. Hilar plate glissonian sheath preservation…2016 American Transplant Congress
The Effect of Families on Organ Donation Among Native Americans.
Background: Prevalence of end-stage renal disease is 3.5 times greater among the >2.5 million Native Americans (NAs) in the US than in Caucasians, due to…2016 American Transplant Congress
Clinical Usefulness of mRECIST Response to Chemoembolization for Recurrence Prediction of Hepatocellular Carcinoma in Living Donor Liver Transplantation.
Background Predicting risk for recurrence of hepatocellular carcinoma (HCC) following living donor liver transplantation (LDLT) is clinically important.Methods We performed a retrospective study for assessment…2016 American Transplant Congress
Prospective Investigation of the Reliability and Validity of the Live Donor Assessment Tool (LDAT).
Recanati Miller Transplantation Institute, Mount Sinai Hospital, New York, NY.
Purpose: The LDAT was the first psychosocial assessment instrument developed to standardize the live donor (LD) psychosocial evaluation (PsychE). Previously, it was found to be…2016 American Transplant Congress
Living Donor Liver Transplantation for Sick Patients with MELD Score ≥ 35.
Background: The liver transplant candidates with MELD score ≥ 35 were very sick and with high mortality without liver transplantation. All these patients are in…2016 American Transplant Congress
Japanese Multicenter Study of Hepatopulmonary Syndrome in Living Donor Liver Transplantation.
Surgery, Tokyo Women's Medical University, Tokyo, Japan.
It is well known that hepatopulmonary syndrome (HPS) manifested with hypo-oxygenemia secondary to intra-pulmonary shunt has negative impacts on outcomes of liver transplantation in deceased…2016 American Transplant Congress
Barriers to the Wider Utilization of Living Donor Liver Transplantation (LDLT).
Purpose: LDLT reduces waitlist mortality, improves access to transplantation and has post-transplant outcomes that are equivalent to or better than deceased donor transplant. Despite these…2016 American Transplant Congress
Early Enteral Feeding After Living Donor Liver Transplantation Prevents Infectious Complications: A Prospective Pilot Study.
Background: Infectious complications, including bacteria, virus, and fungus, often occur after liver transplantation and are the most frequent cause of in-hospital mortality. The present study…2016 American Transplant Congress
Impact of Ideal Body Weight vs. Actual Body Weight for the Prediction of Small for Size Syndrome and Graft Loss After Living Donor Liver Transplantation.
Transplantation, Toronto General Hospital, Toronto, ON, Canada.
Introduction: We compared the impact of estimating graft to recipient body weight ratio (GBWR) with actual body weight (ABW) and ideal body weight (IBW) on…
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 18
- Next Page »